Prostatic Catheter Market Size to Hit US$ 372.3 Million by 2034: Fact.MR Analysis

FACT.MRFACT.MR
FACT.MR

Rising Emphasis on Enhancement of Hospitals with Advanced Urology Departments Driving Demand for Prostatic Catheters

Rockville , March 06, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global prostatic catheter market is estimated at US$ 210.8 million in 2024 and is projected to expand at a CAGR of 5.9% from 2024 to 2034.

The prostate gland generates a fluid that is a component of semen. Improved healthcare infrastructure in certain areas may lead to higher detection and management of urological issues, potentially driving up the need for prostatic catheters. Access to well-equipped medical facilities is crucial for diagnosing and treating urological conditions. Enhancing hospitals with state-of-the-art urology departments enhances patient care and supports the utilization of prostatic catheters in clinical settings.

Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9839

Advancements in healthcare infrastructure involve the integration of telemedicine and remote monitoring capabilities. Telehealth solutions can improve patient access to healthcare services, including consultations for prostatic catheter management. International collaboration in healthcare infrastructure development facilitates the exchange of knowledge, expertise, and resources, leading to advancements in prostatic catheter technology on a global scale.

Development of smart prosthetic catheters with features like temperature sensing, pressure monitoring, and real-time data transmission is projected to lead to the use of advanced materials that enhance the comfort, flexibility, and durability of prostatic catheters. Coating technologies could be employed to reduce friction, irritation, and the risk of infection.

Advancements in catheter design may focus on minimizing discomfort and complications associated with long-term catheter use. Development of more ergonomic and patient-friendly designs to improve ease of insertion and removal. Digital Integration of smart technologies and sensors into catheters for continuous monitoring of relevant health parameters. Connectivity features enable remote monitoring by healthcare providers, potentially improving patient care and outcomes.

Report Attribute

Details

Value Projection (2034)

US$ 372.3 Million

Growth Rate (2024-2034)

5.9% CAGR

No. of pages

170 Pages

No. of Tables

48 Tables

No. of Figures

144 Figures


Key Takeaways from Market Study

  • The global prostatic catheter market is forecasted to reach US$ 372.3 million by the end of 2034.

  • The United States market is estimated at US$ 67.1 million in 2024.

  • Technological advancements in diagnostics and an increasingly proactive regulatory environment are complementing market growth in Germany.

  • Demand for prostatic catheters in Brazil is projected to increase at a CAGR of 4.1% through 2034.

  • Demand for coudé catheters is forecasted to rise at a CAGR of 6.2% from 2024 to 2034.

“Demand for prostatic catheters is being driven by expanding elderly population, rising incidence of prostate-related health issues, and technological advancements. Innovations in catheter design minimize discomfort and complications, thus improving patient outcomes,” says a Fact.MR analyst.

Key Companies Profiled in This Report

  • Angio Dynamics

  • B. Braun Melsungen AG.

  • Boston Scientific Corporation.

  • Coloplast Group

  • Conva Tec Group PLC

  • Cook Medical Inc.

  • Hollister Inc.

  • Medline Industries Inc.

  • Medtronic Plc

  • Teleflex Inc.

  • Wellspect Healthcare

  • Stryker

  • Becton Dickinson and Company

  • Consure Medical

Competitive Analysis

Companies are actively engaging in strategic collaborations and partnerships with other industry players, research institutions, and healthcare organizations. Collaborations are fostering innovation and enhancing the overall competitiveness of key market players. Partnership agreements for the development of new advanced catheters are boosting their market reach and profits.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9839

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the prostatic catheter market, presenting historical demand data for 2019 to 2023 and forecast statistics for 2024 to 2034.

The study divulges essential insights on the market based on product type (coudé catheters [tapered tip coudé catheters, olive tip coudé catheters, Tiemann tip coudé catheters], male closed system catheters [pre-lubricated & hydrophilic male catheters, others], and straight male catheters), application (urinary incontinence, urinary retention, benign prostatic hyperplasia/prostrate surgeries, spinal cord injuries), and end user (hospitals, specialty clinics, ambulance surgical centers), across major regions of the world (North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, and MEA).

Explore More Related Studies Published by Fact.MR Research:

Prostate Cancer Diagnostics Market: The prostate cancer diagnostics landscape is expected to surpass a staggering value of US$ 8 Bn by 2031.

Urinary Catheters Market: Worldwide urinary catheter sales are valued at US$ 6.04 billion in 2023. The global urinary catheters market is projected to register 6.5% CAGR and reach a valuation of US$ 11.34 billion by 2033.

Benign Prostatic Hyperplasia Treatment Market: The global benign prostatic hyperplasia (BPH) treatment market size was valued at US$ 27.7 Billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5% from 2022 to 2032.

About Fact.MR:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog


Advertisement